Secteur Palvella Therapeutics, Inc.

Actions

PVLA

US6979471090

Recherche biotechnologique et médicale

Marché Fermé - Nasdaq 22:00:00 27/07/2026 Varia. 5j. Varia. 1 janv.
141,77 USD +2,72% Graphique intraday de Palvella Therapeutics, Inc. +14,19% +35,44%
Principaux concurrents
Varia. Varia. 5j. Variation 1 mois Variation 3 mois Varia. 1 janv. Varia. 1an Varia. 3ans Varia. 5ans Varia. 10ans Capi.($)
+2,72%+14,19%-8,44%+10,21%+35,44%+255,58% - - - 1,98 Md
-1,82%+5,03%+0,69%+18,55%+10,18%+56,71%+66,69%+201,68%+6 013,00% 57,28 Md
-0,27%+5,74%+5,48%+24,56%+37,53%+40,26%+80,17%-16,19% - 54,99 Md
-2,05%-2,14%-0,01%-22,98%-39,82%+2,93%+413,38%+339,86%+821,92% 23,18 Md
+1,97%-1,16%-3,36%-10,75%-4,32%-19,24%-13,25%-67,93% - 22,59 Md
-1,13%+4,54%+17,01%+15,33%+22,96%+22,73%-8,06%-66,96% - 20,46 Md
+1,57%+2,09%+12,10%+11,51%-5,87%+28,01%-27,56%-31,88%+57,69% 17,56 Md
-0,10%+5,57%+22,85%+7,47%+30,93%+38,63%+565,16% - - 15,67 Md
+5,29%0,00%+14,77%+113,80%+182,04%+185,09%+332,66%+1 569,75%+674,23% 14,46 Md
+0,79%+0,50%+2,82%+24,99%+27,33%+25,73%+184,74%+235,20%+537,10% 13,92 Md
+1,24%+2,90%+4,55%+5,99%-5,34%+87,40%+175,74%+544,21%+7 250,00% 12,55 Md
-0,08%+19,37%+6,25%+16,21%+28,83%+427,96%+138,71%+29,69%+1 323,13% 12,06 Md
-0,90%+11,60%+18,37%-25,08%-12,74%-33,87%+153,80%+104,56% - 11,69 Md
-0,15%+1,91%-7,61%+30,88%+26,88%+120,09%+150,14%+186,80%+678,19% 10,96 Md
-4,06%-2,93%-8,48%-40,75%-25,07%-52,26%+579,02%+73,12%+83,29% 10,9 Md
-2,05%+2,78%+10,96%+39,14%+205,37%+489,16%+613,68%-39,64%-14,86% 8,98 Md
+0,14%-0,02%+126,99%+117,12%+80,13%+176,73%+354,23%+374,80% - 8,83 Md
+1,64%+5,67%+29,67%+27,15%+16,37%+26,04%+322,89%+324,67% - 7,92 Md
+1,54%0,00%-3,85%-7,07%+20,29%+54,73%+20,05%+152,85% - 7,89 Md
-1,55%-6,74%-20,30%-4,12%+253,03%+163,77%+200,00%-35,10% - 7,44 Md
Moyenne +0,19%+0,54%+11,02%+17,61%+44,21%+104,81%+226,43%+215,53%+1 742,37% 17,06 Md
Moyenne pondérée par Capi. -0,16%+1,80%+8,39%+16,62%+30,58%+72,12%+175,56%+181,61%+2 732,34%
Médicaments bio-thérapeutiques
  1. Bourse
  2. Actions
  3. Action PVLA
  4. Secteur Palvella Therapeutics, Inc.